Grace Therapeutics
GRCE
#9751
Rank
ยฃ40.3 M
Marketcap
ยฃ2.60
Share price
-0.10%
Change (1 day)
-20.36%
Change (1 year)

Revenue for Grace Therapeutics (GRCE)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Grace Therapeutics from 2010 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A-100%
2021 ยฃ0.08 M43.37%
2020 ยฃ0.05 M
2019 N/A
2018 N/A
2016 ยฃ0 M-88.86%
2015 ยฃ0.08 M-44.85%
2014 ยฃ0.14 M-19.71%
2013 ยฃ0.18 M-58.18%
2012 ยฃ0.43 M471.7%
2011 ยฃ0.07 M
2010 N/A